Iran (Islamic Republic of) vs Northern America: Proportion of the target population … measles-containing-vaccine
Iran (Islamic Republic of)
99.0%
in 2024
Northern America
94.0%
in 2024
Iran (Islamic Republic of) rank
1st
Northern America rank
4th
Proportion of the target population … measles-containing-vaccine over time
- Iran (Islamic Republic of)
- Northern America
How they compare
Iran (Islamic Republic of) currently reports 99.0% against 94.0% in Northern America, a difference of 5.0%.
That makes Iran (Islamic Republic of)'s figure about 1.1 times Northern America's.
Across all 25 years both countries report, Iran (Islamic Republic of) has been ahead every year.
Iran (Islamic Republic of) ranks 1st and Northern America ranks 4th of 195 countries.
Iran (Islamic Republic of) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iran (Islamic Republic of) | Northern America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.6% | 79.2% | 17.4% | Iran (Islamic Republic of) |
| 2010s | 98.0% | 90.0% | 8.0% | Iran (Islamic Republic of) |
| 2020s | 98.4% | 94.0% | 4.4% | Iran (Islamic Republic of) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Iran (Islamic Republic of) or Northern America?
- Iran (Islamic Republic of), at 99.0% against 94.0% in Northern America as of 2024.
- What is the difference in proportion of the target population who received between Iran (Islamic Republic of) and Northern America?
- 5.0%, with Iran (Islamic Republic of) ahead.
- How many years of comparable data are there for Iran (Islamic Republic of) and Northern America?
- 25 years are reported by both, from 2000 to 2024.
- How do Iran (Islamic Republic of) and Northern America rank globally for proportion of the target population who received?
- Iran (Islamic Republic of) ranks 1st and Northern America ranks 4th of 195 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.